Kliničke studije za KOPB u državi Oklahoma
8 studija za KOPB traži sudionike na lokacijama u državi Oklahoma.
Gradovi u državi Oklahoma
Službeni tekst studije (engleski)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Norman
- Research Site, Oklahoma City
- Research Site, Tulsa
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Layrek Clinical Research- Site Number : 8400066, Tulsa
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Oklahoma City
- Research Site, Tulsa
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Oklahoma City
- Research Site, Tulsa
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Oklahoma City
U tijeku regrutacijaFaza 3
Od 40 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06883305eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Edmond
U tijeku regrutacijaFaza 3
Od 40 do 75 godina · Oba spola · Ažurirano 28. srp 2026. · NCT07177339Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Hightower Clinical, Oklahoma City
U tijeku regrutacijaOpažajna studija
Od 50 godina i više · Oba spola · Ažurirano 5. kol 2025. · NCT06122077Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.